Duane Gubler, an internationally recognized expert on dengue fever, has taken on the post of Director – Emerging Infectious Diseases research program at the Duke-NUS Graduate Medical School in Singapore. His appointment was effective Nov. 1, 2007.
Phil Costanzo writes Duke ChroniclePart 7 in a series on global health in the Duke Chronicle. Obesity is an important focus of global health efforts today because it is a premorbid state that can be preventable with increases in our scientific understanding of the sources of its “spread.”
The stories on the evening news about the tragic health problems that plague people in developing nations can seem very far removed from North Carolina. But when it comes to global health, the world is a small place indeed.
AIDS/HIV continues to be a major health problem in the U.S., with African-Americans in the rural south particularly at risk. The Substance Abuse and Mental Health Services Administration (SAMHSA) is providing nearly $2.5 million to fund CADET (the Carolina Alcohol and Drug Abuse Expansion Team).
HIV-infected patients in the African country of Tanzania were more likely to stop taking their medications and to fail treatment if they had to pay for the drugs themselves.
Since 2000, the rates of HIV testing have remained relatively low and constant in the United States, with about one third of Americans ever having had an HIV test, and less than a quarter of the people considered at high risk for contracting the virus that causes AIDS report having been tested in the past year.
The Human Vaccine Institute at Duke University Medical Center has been awarded a $7.6 million contract from the National Institute of Allergy and Infectious Diseases (NIAID) to expand its efforts to standardize and improve the quality
of a crucial blood test used in the treatment of millions of HIV patients worldwide.
Duke University will receive $35 million from billionaire real estate developer David H. Murdock to support a massive biomedical research project at the North Carolina Research Campus (NCRC) in Kannapolis, N.C., university president Richard H. Brodhead, Ph.D., and Chancellor for Health Affairs Victor J. Dzau, M.D., announced Monday.
A study examining whether treatment of herpes simplex virus-2 (HSV-2) lowers risk of becoming HIV-infected among women in Tanzania resulted in no difference in HIV infections. But did the trial take into account the issues of adherence to treatment that may have skewed results? Male circumcision may reduce transmission of some sexually transmitted infections, including HIV, but does this knowledge raise the chances that a circumcised man will increase risky sexual behavior?